Skip to main content
. 2014 Jun 26;461(Pt 2):213–222. doi: 10.1042/BJ20140189

Table 2. Inhibition of cell–cell fusion by PBDK–sphing, PBDK and sphinganine.

Inhibition of cell–cell fusion: TZM-bl target cells were mixed with HL2/3 effector cells in the presence of different compounds. IC50 (concentration achieving 50% inhibition of infection) and IC90 (concentration achieving 90% inhibition of infection) values for each compound were calculated via luciferase expression as described in the Materials and methods section.

Designation IC50 (μM) IC90 (μM)
Sphinganine >1.5 >14
PBDK >1.5 >14
PBDK–sphing 0.88±0.07 2.24±0.75